Cargando…

Combining vasculature disrupting agent and toll-like receptor 7/8 agonist for cancer therapy

This study evaluates the effect of combination of two different treatment regimens for solid tumor therapy: vasculature targeting agent and immune-stimulation. Poly lactide-co-glycolide (PLGA) nanoparticles were synthesized for intracellular delivery of toll-like receptor (TLR) 7/8 agonist—gardiquim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seth, Anushree, Lee, Hyunseung, Cho, Mi Young, Park, Cheongsoo, Korm, Sovannarith, Lee, Joo-Yong, Choi, Inpyo, Lim, Yong Taik, Hong, Kwan Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354915/ https://www.ncbi.nlm.nih.gov/pubmed/28036266 http://dx.doi.org/10.18632/oncotarget.14260

Ejemplares similares

RAP80 regulates epithelial–mesenchymal transition related with metastasis and malignancy of cancer
por: Park, Song Yi, et al.
Publicado: (2016)

Size-regulated group separation of CoFe(2)O(4) nanoparticles using centrifuge and their magnetic resonance contrast properties
por: Kang, Jongeun, et al.
Publicado: (2013)

Failure to Guard: Mitochondrial Protein Quality Control in Cancer
por: Friedlander, Joseph E., et al.
Publicado: (2021)

Conditional ablation of macrophages disrupts ovarian vasculature
por: Turner, Emily C, et al.
Publicado: (2011)

Vasculature Disruption Enhances Bacterial Targeting of Autochthonous Tumors
por: Drees, Jeremy J., et al.
Publicado: (2015)

α-Ketoglutarate-Mediated DNA Demethylation Sustains T-Acute Lymphoblastic Leukemia upon TCA Cycle Targeting
por: Wang, Yanwu, et al.
Publicado: (2022)

Hypoxia-Directed and Self-Immolative Theranostic Agent: Imaging and Treatment of Cancer and Bacterial Infections
por: Karan, Sanu, et al.
Publicado: (2023)

Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2020)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

MR Assessment of Acute Pathologic Process after Myocardial Infarction in a Permanent Ligation Mouse Model: Role of Magnetic Nanoparticle-Contrasted MRI
por: Park, Cheongsoo, et al.
Publicado: (2017)

Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular Edema
por: Agard, Nicholas J., et al.
Publicado: (2022)

The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts
por: Fung, Andrea S, et al.
Publicado: (2015)

Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature
por: Schiffrin, Ernesto L
Publicado: (2010)

Hyperglycaemia disrupts conducted vasodilation in the resistance vasculature of db/db mice
por: Lemmey, Hamish A.L., et al.
Publicado: (2018)

Sonoselective transfection of cerebral vasculature without blood–brain barrier disruption
por: Gorick, Catherine M., et al.
Publicado: (2020)

Gambogic Acid Disrupts Toll-like Receptor4 Activation by Blocking Lipopolysaccharides Binding to Myeloid Differentiation Factor 2
por: Lee, Jin Young, et al.
Publicado: (2015)

ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine
por: Kim, Sehui, et al.
Publicado: (2023)

Multiple Signaling Molecules are Involved in Expression of CCL2 and IL-1β in Response to FSL-1, a Toll-Like Receptor 6 Agonist, in Macrophages
por: Won, Keunsoo, et al.
Publicado: (2012)

Self-Assembled Polyelectrolyte Nanoparticles as Fluorophore-Free Contrast Agents for Multicolor Optical Imaging
por: Shin, Da Hye, et al.
Publicado: (2015)

Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
por: Deng, Shuanglin, et al.
Publicado: (2014)

Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
por: Simpson-Haidaris, P. J., et al.
Publicado: (2010)

Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
por: Song, Chanyoung, et al.
Publicado: (2019)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
por: Rolfo, Christian, et al.
Publicado: (2023)

FSL-1, a Toll-like Receptor 2/6 Agonist, Induces Expression of Interleukin-1α in the Presence of 27-hydroxycholesterol
por: Heo, Weon, et al.
Publicado: (2014)

An Activatable T(1)-Weighted MR Contrast Agent: A Noninvasive Tool for Tracking the Vicinal Thiol Motif of Thioredoxin in Live Cells
por: Kang, Jongeun, et al.
Publicado: (2021)

The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists in oncological indications
por: Aranda, Fernando, et al.
Publicado: (2014)

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
por: Chi, Huju, et al.
Publicado: (2017)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
por: Huang, Lingling, et al.
Publicado: (2022)

Current Perspective on In Vivo Molecular Imaging of Immune Cells
por: Seth, Anushree, et al.
Publicado: (2017)

The invasive pathogen Yersinia pestis disrupts host blood vasculature to spread and provoke hemorrhages
por: Mikaty, Guillain, et al.
Publicado: (2021)

Targeted disruption of tumor vasculature via polyphenol nanoparticles to improve brain cancer treatment
por: Liu, Fuyao, et al.
Publicado: (2022)

Partial Mural Cell Ablation Disrupts Coronary Vasculature Integrity and Induces Systolic Dysfunction
por: Cornuault, Lauriane, et al.
Publicado: (2023)

Emerging Roles of Lymphatic Vasculature in Immunity
por: Kim, Ki-Wook, et al.
Publicado: (2017)

Radioprotective effect of newly synthesized toll-like receptor 5 agonist, KMRC011, in mice exposed to total-body irradiation
por: Kim, Jun-Young, et al.
Publicado: (2019)

Gold nanoparticles as high-resolution X-ray imaging contrast agents for the analysis of tumor-related micro-vasculature
por: Chien, Chia-Chi, et al.
Publicado: (2012)

DLST-dependence dictates metabolic heterogeneity in TCA-cycle usage among triple-negative breast cancer
por: Shen, Ning, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_po8is7ghonuc1b0fiug1ppnfqi